Overexpression of SphK1 and differential S1PRs distribution are associated with poor prognosis and disease stage in breast cancer and may prove to be strong candidates as diagnostic and prognositic markers for ER+ and ER- breast cancers, endocrine resistance, and metastasis [11, 230, 340]. This evidence concerns the gene ESR1 and breast carcinoma.